Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,757 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and Efficacy of Low-dose Nanoparticle Albumin-bound Paclitaxel for HER2-negative Metastatic Breast Cancer.
Takashima T, Kawajiri H, Nishimori T, Tei S, Nishimura S, Yamagata S, Tokunaga S, Mizuyama Y, Sunami T, Tezuka K, Ikeda K, Ogawa Y, Kashiwagi S, Noda S, Onoda N, Ishikawa T, Kudoh S, Takada M, Hirakawa K, Ohira M. Takashima T, et al. Among authors: takada m. Anticancer Res. 2018 Jan;38(1):379-383. doi: 10.21873/anticanres.12233. Anticancer Res. 2018. PMID: 29277798
A phase II, multicenter, single-arm trial of eribulin as first-line chemotherapy for HER2-negative locally advanced or metastatic breast cancer.
Takashima T, Tokunaga S, Tei S, Nishimura S, Kawajiri H, Kashiwagi S, Yamagata S, Noda S, Nishimori T, Mizuyama Y, Sunami T, Tezuka K, Ikeda K, Ogawa Y, Onoda N, Ishikawa T, Kudoh S, Takada M, Hirakawa K. Takashima T, et al. Among authors: takada m. Springerplus. 2016 Feb 24;5:164. doi: 10.1186/s40064-016-1833-1. eCollection 2016. Springerplus. 2016. PMID: 27026861 Free PMC article.
Phase I study of nanoparticle albumin-bound paclitaxel, carboplatin and trastuzumab in women with human epidermal growth factor receptor 2-overexpressing breast cancer.
Tezuka K, Takashima T, Kashiwagi S, Kawajiri H, Tokunaga S, Tei S, Nishimura S, Yamagata S, Noda S, Nishimori T, Mizuyama Y, Sunami T, Ikeda K, Ogawa Y, Onoda N, Ishikawa T, Kudoh S, Takada M, Hirakawa K. Tezuka K, et al. Among authors: takada m. Mol Clin Oncol. 2017 Apr;6(4):534-538. doi: 10.3892/mco.2017.1176. Epub 2017 Feb 24. Mol Clin Oncol. 2017. PMID: 28413662 Free PMC article.
Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Trastuzumab Followed by 5-Fluorouracil/Epirubicin/Cyclophosphamide for HER2-positive Operable Breast Cancer: A Multicenter Phase II Trial.
Tokunaga S, Takashima T, Kashiwagi S, Noda S, Kawajiri H, Tokumoto M, Nishimura S, Nishimori T, Ikeda K, Ogawa Y, Mizuyama Y, Sunami T, Tezuka K, Yamagata S, Ishikawa T, Kudoh S, Takada M, Hirakawa K, Ohira M. Tokunaga S, et al. Among authors: takada m. Anticancer Res. 2019 Apr;39(4):2053-2059. doi: 10.21873/anticanres.13316. Anticancer Res. 2019. PMID: 30952749 Clinical Trial.
An Exploratory Phase II Study of Eribulin Re-challenge After Short Term Therapy of 5-Fluorouracil for HER2 Negative, Advanced or Recurrent Breast Cancer.
Takashima T, Nishimura S, Kawajiri H, Mizuyama Y, Nishimori T, Yamagata S, Tokunaga S, Tezuka K, Tei S, Sunami T, Ikeda K, Ogawa Y, Kashiwagi S, Noda S, Onoda N, Ishikawa T, Kudoh S, Takada M, Hirakawa K, Ohira M. Takashima T, et al. Among authors: takada m. Anticancer Res. 2021 Oct;41(10):5007-5014. doi: 10.21873/anticanres.15315. Anticancer Res. 2021. PMID: 34593449 Clinical Trial.
Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trial.
Sawa T, Yana T, Takada M, Sugiura T, Kudoh S, Kamei T, Isobe T, Yamamoto H, Yokota S, Katakami N, Tohda Y, Kawakami A, Nakanishi Y, Ariyoshi Y. Sawa T, et al. Among authors: takada m. Invest New Drugs. 2006 Mar;24(2):151-8. doi: 10.1007/s10637-006-5937-2. Invest New Drugs. 2006. PMID: 16502350 Clinical Trial.
Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904).
Kudoh S, Takeda K, Nakagawa K, Takada M, Katakami N, Matsui K, Shinkai T, Sawa T, Goto I, Semba H, Seto T, Ando M, Satoh T, Yoshimura N, Negoro S, Fukuoka M. Kudoh S, et al. Among authors: takada m. J Clin Oncol. 2006 Aug 1;24(22):3657-63. doi: 10.1200/JCO.2006.06.1044. J Clin Oncol. 2006. PMID: 16877734 Clinical Trial.
Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515.
Yoshida K, Sugiura T, Takifuji N, Kawahara M, Matsui K, Kudoh S, Takada M, Fukuoka M, Ariyoshi Y, Fukuda H, Saijo N. Yoshida K, et al. Among authors: takada m. Lung Cancer. 2007 Dec;58(3):362-8. doi: 10.1016/j.lungcan.2007.07.009. Epub 2007 Aug 22. Lung Cancer. 2007. PMID: 17716779 Clinical Trial.
1,757 results